New book by Larry Connors Click here Improve your trading - See how
DayTradersDigest.com is part of Stock Profiler.US, LLC's News Division. Stock Profiler welcomes investors to chat LIVE about these stocks and more on their upgraded website with FREE Investor Tools, Live Chats, and much more! Sign up now at www.stockprofiler.us. Companies who want to broadcast their message are encouraged to contact Stock Profiler.US, LLC at (603) 424-4420.
-------------------------------------------
VIVUS, Inc. (NASDAQ: VVUS | Quote | Chart | News | PowerRating) closed at $8.95 Monday, trading 500,200 shares.
Company News- September 9, 2008: VIVUS to Present at the Merriman Curhan Ford Investor Summit 2008
VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, announced earlier today that Timothy Morris, vice president and CFO, will present at the Merriman Curhan Ford Investor Summit at the Mark Hopkins Hotel, San Francisco.
The VIVUS presentation will take place on Monday September 15, 2008 at 9:30 a.m. PT. A live audio webcast and 14-day archive of the presentation will be available at http://ir.vivus.com.
About VIVUS
VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products. The current portfolio includes investigational products addressing obesity, diabetes and sexual health. The pipeline includes: Qnexa, which is in phase 3 for the treatment of obesity and phase 2 for the treatment of type 2 diabetes; Testosterone MDTS , for which a phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); and avanafil, for which a phase 2 study has been completed for the treatment of erectile dysfunction (ED). For more information on clinical trials and products, please visit the company's web site at http://www.vivus.com.
About Merriman Curhan Ford
Merriman Curhan Ford (NASDAQ:MERR) is a financial services firm focused on fast-growing companies and the institutions who invest in them. The company offers high-quality investment banking, equity research, institutional services, primary market research, asset management and corporate & venture services, and specializes in four growth industry sectors: CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. For more information, please go to www.mcfco.com.
-------------------------------------------
XTend Medical Corporation (PINKSHEETS: XMDC | Quote | Chart | News | PowerRating) closed at $0.0006 Monday, trading 9,853,282 shares.
Company News- September 9, 2008: XTend Medical (XMDC) Signs Agreement With AmeriChoice, a Division of United Health Group, to Begin Remote Diabetic Patient Monitoring Program
XTend Medical Corporation (PINKSHEETS: XMDC), a company that delivers cutting-edge telemedicine solutions to the healthcare industry, announced earlier today the company has signed an agreement to begin a Remote Diabetic Patient Monitoring Program with AmeriChoice, a division of United Health Group, the largest healthcare provider in the U.S.
"Through the hard work and perseverance of Mr. Jose Santoro of Medical Cost Management, and the management here at XTend Medical, we're proud to announce the company has an agreement in place to begin remotely monitoring diabetic patients with the largest managed care company here in the U.S. This agreement will deliver to AmeriChoice a comprehensive solution that will allow their diabetic patients to be remotely monitored and communicate results in order to effectively assist patients in managing their diabetes," stated Mr. Paul D. Lisenby, CEO of XTend Medical. Mr. Lisenby further states, "This clearly distances XTend Medical from our competition. With this agreement in place, XTend Medical is in a very advantageous position in the marketplace. We've worked hard to deliver the best cutting-edge telemedicine solutions to managed care companies, physicians, and patients and now the company is poised to break through and offer additional healthcare companies seeking the very best in remote monitoring programs for diabetics here in the U.S. and globally." For any healthcare agency of physician group that would like to find more about the how XTend can assist in your management of diabetic patients, please visit the company website at www.xtendmedical.com or email us at info@xtendmedical.com
About XTend Medical
XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. XTend has developed a complete Remote Diabetic Patient Monitoring System that is currently being used by physicians and other healthcare agencies throughout the U.S. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. For more information, please visit their website at www.xtendmedical.com
-------------------------------------------
The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. DayTradersDigest.com is a division of Stock Profiler.US, LLC's News Division, which includes but is not limited to www.stockprofiler.us, www.businessnetwire.us, www.financialbusinessnews.us, www.markettelegraph.com, www.associatesfortune.com, www.thewallstreetleader.com and www.fastmoneytalk.com. Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers and terms of use, go to www.stockprofiler.us.
Keywords: Small Cap Investments, Investor Relations, I/R Services, Investment Tools, Stock Profiles, Stock Market Quotes News, Media Coverage
CONTACT: Daytradersdigest.com Tel: +1 603 424 4420 e-mail: info@stockprofiler.us WWW: http://www.daytradersdigest.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
